Abstract
Our study analyzes potential savings and losses for Medicare Part D using Mark Cuban Cost Plus Drug Company (MCCPDC) as an alternative medication procurement method for the 75 most commonly prescribed medications by otolaryngologists in 2022. Monthly standard MCCPDC costs and imputed Medicare Part D monthly costs for each prescription medication were compared. Our results indicated heterogenous efficiency of sourcing medications through MCCPDC due to some potential cost savings but other substantial losses. 45.3% of the top 75 otolaryngologic prescription medications sorted by total spending were not available on MCCPDC, indicating the need for more affordable access to expensive medications. Additionally, antibiotics consistently displayed potential losses through MCCPDC procurement, suggesting Medicare’s ability to achieve discount pricing for particular drug categories. Hence, providers should consider utilizing direct-to-consumer (DTC) models on a case-by-case basis, and future cost-saving investigations including additional DTC models should be conducted.
Keywords: Mark Cuban Cost Plus Drug Company, Medicare Part D, Cost Savings, Otolaryngology, Drug Distribution
Introduction
The Medicare Part D program is designed to help beneficiaries pay for prescription medications and control out-of-pocket expenses [1]. Due to intermediaries involved between manufacturers and consumers, prescription medications are often subject to significant price markups within distribution models despite having generic counterparts. This burden is heightened by restrictions on Medicare’s ability to negotiate drug prices and set preferred generic manufacturers, which increases monthly premiums and out-of-pocket (OOP) costs for Medicare beneficiaries [2]. In response, MCCPDC was created in January 2022 as a direct-to-consumer (DTC) company. Previous studies have shown Medicare overspending in comparison with DTC approaches, such as the Mark Cuban Cost Plus Drug Company (MCCPDC), that could save a minimum of $1.29 billion, $661.8 million, $64.5 million on urologic, oncologic, and ophthalmologic medications, respectively [2, 3, 4].
Methods
This study analyzes availability and potential savings if Medicare Part D sourced medications directly from MCCPDC for the 75 medications most commonly prescribed by otolaryngologists in 2022. We utilized data from the Center for Medicare and Medicaid Services (CMS) files and the MCCPDC website. Although numerous DTC models exist, we selected MCCPDC due to its relative newness to the market, making it attractive to investigate from a specialty-specific perspective, and its fixed cost-plus-pricing approach. Medications on MCCPDC are sold at a fixed 15% markup, $5 pharmacy service fee, and $5 shipping fee. Each form of the medication was reported individually, and quantity was held at the smallest count for each available form, either 1- or 30-count. Monthly standard cost was taken as an average of all strength variations. All brand name alternatives found on MCCPDC were included to provide consistency and account for off-label usage. Although every medication form was included within the tables, medications with multiple forms were excluded from our top 10 savings and losses categories in our results section to prevent inaccurate estimations due to unclear delineation of forms in the Medicare Part D database. Shipping costs set at $5 per order on the MCCPDC website were excluded from the final monthly value as their inclusion could overestimate total costs for customers ordering > 1 medication. To account for inflation, 2022 Medicare prices were adjusted to estimate 2024 prices using the National Average Drug Acquisition Cost data.
Results
Of the 75 medications prescribed by otolaryngologists with the most claims, 23 (30.7%) were not available on the MCCPDC website (Table 1). The 10 medications associated with the highest savings on MCCPDP were Azelastine HCL - Optivar ($10,580,178.71), Azelastine HCL - Astelin ($9,925,397.15), Fluticasone Propionate – Flonase ($5,692,152.58), Mometasone Furoate – Nasonex ($1,213,744.20), Tobramycin/Dexamethasone ($706,543.95), Azelastine/Fluticasone ($703,066.54), Cefdinir ($561,403.80), Pilocarpine HCL – Salagen ($514,365.97), Esomeprazole Magnesium ($458,072.68), Doxycycline Hyclate – Lymepak ($437,875.68). If the ten listed medications were purchased from MCCPDC, estimated annual costs would be 47.7% of total expenditure by Medicare Part D, totaling $30,334,728.58 in potential monthly savings.
Table 1.
Savings profile for the top 75 otolaryngology medications by total 2022 prescription fills
| Medication | Dose (Strength: Volume) | Form | Total 2022 Medicare Part D Spending | Total 2022 30-Day Prescriptions in Medicare Part D | Imputed Monthly Costs for Medicare Part D ($) | Monthly Standard MCCPDC ($) | Potential Savings ($) |
|---|---|---|---|---|---|---|---|
| Fluticasone Propionate (Flonase) | 50mcg:16mL | Nasal Spray | 17,543,104.21 | 1,136,158.20 | 15.45 | 10.44 | 5,692,152.58 |
| Fluticasone Propionate (Cutivate) | 0.005%:15 g | Tube of Ointment | 17,543,104.21 | 1,136,158.20 | 15.45 | 10.87 | 5,203,604.56 |
| Fluticasone Propionate (Cutivate) | 0.05%:60mL | Bottle of Lotion | 17,543,104.21 | 1,136,158.20 | 15.45 | 128.65 | (128,613,108.24) |
| Fluticasone Propionate (Cutivate) | 0.05%:60 g | Cream | 17,543,104.21 | 1,136,158.20 | 15.45 | 20.18 | (5,374,028.29) |
| Fluticasone Propionate (Cutivate) | 0.005%:60gm | Ointment | 17,543,104.21 | 1,136,158.20 | 15.45 | 29.71 | (16,201,615.93) |
| Azelastine Hcl (Astelin) | 0.1%:30mL | Nasal Spray | 15,635,459.03 | 545,651.30 | 28.66 | 10.47 | 9,925,397.15 |
| Azelastine Hcl (Optivar) | 0.05%:6mL | Solution | 15,635,459.03 | 545,651.30 | 28.66 | 9.27 | 10,580,178.71 |
| Ipratropium Bromide | 0.02%:30 × 2.5mL | Vial of Solution | 16,796,060.76 | 520,094.30 | 32.3 | 14.58 | 9,216,071.00 |
| Ipratropium Bromide | 0.06%:15mL | Nasal Spray | 16,796,060.76 | 520,094.30 | 32.3 | 20.53 | 6,121,509.91 |
| Ipratropium Bromide | 0.03%:30mL | Nasal Spray | 16,796,060.76 | 520,094.30 | 32.3 | 20.53 | 6,121,509.91 |
| Omeprazole | 20 mg | Delayed Release Capsule | 3,455,167.27 | 482,381.70 | 7.17 | 6.35 | 395,552.99 |
| Famotidine | 10 mg, 20 mg, 40 mg | Tablet | 3,264,958.02 | 444,454.80 | 7.35 | 6.20 | 511,123.02 |
| Famotidine | 40 mg / 5mL:50mL | Suspension 50mL | 3,264,958.02 | 444,454.80 | 7.35 | 25.70 | (8,155,745.58) |
| Montelukast Sodium | 10 mg | Tablet | 3,222,638.37 | 432,946.80 | 7.45 | 6.20 | 541,183.50 |
| Montelukast Sodium | 4 mg | Packet | 3,222,638.37 | 432,946.80 | 7.45 | 34.10 | (11,538,032.22) |
| Montelukast Sodium | 4 mg, 5 mg | Packet | 3,222,638.37 | 432,946.80 | 7.45 | 6.80 | 281,415.42 |
| Prednisone | 5 mg:21 Tablets, 10 mg:48 Tablets | Tablet Therapy Pack | 767,596.02 | 154,360.00 | 4.98 | 13.85 | (1,369,173.20) |
| Prednisone | 1 mg, 2.5 mg, 5 mg, 10 mg, 20 mg, 50 mg | Tablet | 767,596.02 | 154,360.00 | 4.98 | 7.60 | (404,423.20) |
| Prednisone | 5 mg/5mL:120mL | Bottle of Solution | 767,596.02 | 154,360.00 | 4.98 | 85.10 | (12,367,323.20) |
| Mupirocin | 2%:22 g | Ointment | 1,387,342.74 | 130,041.40 | 10.67 | 7.25 | 444,741.59 |
| Mupirocin | 2%:15 g,30 g | Cream | 1,387,342.74 | 130,041.40 | 10.67 | 19.54 | (1,153,467.22) |
| Amoxicillin/Potassium Clav | 1000-62.5 mg | Extended Release Tablet | 1,906,399.91 | 123,787.60 | 15.41 | 206.00 | (23,592,678.68) |
| Pantoprazole Sodium | - | - | 1,617,809.41 | 208,988.60 | 7.75 | - | - |
| Methylprednisolone | 4 mg:21 pack | Blister Pack of 21 Tablets | 918,420.00 | 98,303.80 | 9.35 | 7.74 | 158,269.12 |
| Methylprednisolone | 4 mg, 8 mg, 16 mg, 32 mg | Tablet | 918,420.00 | 98,303.80 | 9.35 | 42.28 | (3,237,144.13) |
| Ofloxacin (Floxin) | 300 mg, 400 mg | Tablet | 4,777,483.44 | 95,881.70 | 49.83 | 380.30 | (31,686,025.40) |
| Ofloxacin (Ocuflox) | 0.3%:5mL | Ophthalmic Solution − 5mL | 4,777,483.44 | 95,881.70 | 49.83 | 14.11 | 3,424,894.32 |
| Ofloxacin (Ocuflox) | 0.3%:10mL | Ophthalmic Solution − 10mL | 4,777,483.44 | 95,881.70 | 49.83 | 15.30 | 3,310,795.10 |
| Mometasone Furoate (Nasonex) | 50mcg:17 g | Suspension | 3,467,521.34 | 72,203.70 | 48.03 | 31.22 | 1,213,744.20 |
| Mometasone Furoate (Elocon) | 0.10%:45 g | Cream | 3,467,521.34 | 72,203.70 | 48.03 | 14.15 | 2,446,261.36 |
| Mometasone Furoate (Elocon) | 0.10%:45 g | Ointment | 3,467,521.34 | 72,203.70 | 48.03 | 18.70 | 2,117,734.52 |
| Varicella-Zoster Ge/As01b/Pf | - | - | 16,061,601.00 | 83,030.00 | 193.45 | - | - |
| Hydrocodone/Acetaminophen | - | - | 609,375.58 | 73,699.00 | 8.27 | - | - |
| Levocetirizine Dihydrochloride | 5 mg | Tablet | 1,208,263.83 | 127,773.90 | 9.46 | 6.50 | 378,210.74 |
| Levocetirizine Dihydrochloride | 2.5 mg/5mL:148mL | Solution | 1,208,263.83 | 127,773.90 | 9.46 | 23.74 | (1,824,611.29) |
| Levothyroxine Sodium | 25mcg, 75mcg, 100mcg, 137mcg, 150mcg | Tablet | 1,549,498.17 | 144,863.50 | 10.7 | 10.18 | 75,329.02 |
| Azithromycin | 250 mg, 500 mg, 600 mg | Tablet | 402,942.35 | 49,306.20 | 8.18 | 16.80 | (425,019.44) |
| Ciprofloxacin Hcl/Dexameth | - | - | 8,082,874.32 | 49,249.10 | 164.13 | - | - |
| Cephalexin (Keflex) | 250 mg, 500 mg, 750 mg | Capsule | 340,962.72 | 45,353.40 | 7.52 | 86.20 | (3,568,405.51) |
| Cephalexin (Keftab) | 250 mg | Tablet | 340,962.72 | 45,353.40 | 7.52 | 35.60 | (1,273,523.47) |
| Fluocinolone Acetonide Oil | - | - | 3,135,136.19 | 53,615.80 | 58.48 | - | - |
| Doxycycline Hyclate (Doryx) | 50 mg, 75 mg, 100 mg, 150 mg, 200 mg | Tablet Delayed Release | 886,088.40 | 43,098.00 | 20.56 | 54.82 | (1,476,537.48) |
| Doxycycline Hyclate (TargaDOX) | 50 mg | Tablet | 886,088.40 | 43,098.00 | 20.56 | 166.40 | (6,285,412.32) |
| Doxycycline Hyclate (Acticlate) | 75 mg, 150 mg | Tablet | 886,088.40 | 43,098.00 | 20.56 | 17.60 | 127,570.08 |
| Doxycycline Hyclate (Lymepak) | 100 mg | Tablet | 886,088.40 | 43,098.00 | 20.56 | 10.40 | 437,875.68 |
| Doxycycline Hyclate (Vibramycin) | 20 mg | Tablet | 886,088.40 | 43,098.00 | 20.56 | 8.90 | 502,522.68 |
| Doxycycline Hyclate (Vibramycin) | 50 mg, 100 mg | Capsule | 886,088.40 | 43,098.00 | 20.56 | 9.50 | 476,663.88 |
| Cefdinir | 300 mg | Capsule | 1,091,097.58 | 42,402.10 | 25.74 | 12.50 | 561,403.80 |
| Neomycin/Polymyxin B/Hydrocort | 3.5 mg/mL 10,000 unit/mL 1%:10mL | Suspension | 2,425,096.92 | 38,527.60 | 62.95 | 41.40 | 830,269.78 |
| Neomycin/Polymyxin B/Hydrocort | 3.5-10000-1:7.5mL | Solution Dropper | 2,425,096.92 | 38,527.60 | 62.95 | 154.25 | (3,517,569.88) |
| Neomycin/Polymyxin B/Hydrocort | 1%:10mL | Solution | 2,425,096.92 | 38,527.60 | 62.95 | 56.11 | 263,528.78 |
| Ciprofloxacin Hcl | - | - | 363,024.80 | 30,158.50 | 12.04 | - | - |
| Triamterene/Hydrochlorothiazid | 37.5-25 mg | Capsule | 300,703.93 | 59,900.70 | 5.03 | 6.80 | (106,024.24) |
| Amoxicillin | 250 mg, 500 mg | Capsule | 136,005.80 | 24,617.10 | 5.53 | 7.10 | (38,648.85) |
| Amoxicillin | 500 mg, 875 mg | Tablet | 136,005.80 | 24,617.10 | 5.53 | 7.85 | (57,111.67) |
| Amoxicillin | 125 mg, 250 mg | Tablet Chewable | 136,005.80 | 24,617.10 | 5.53 | 13.85 | (204,814.27) |
| Triamcinolone Acetonide (Oralone) | 0.1%:5 g | Paste | 489,660.91 | 24,861.60 | 19.7 | 20.78 | (26,850.53) |
| Triamcinolone Acetonide (Trianex) | 0.05%:430 g | Jar of Ointment | 489,660.91 | 24,861.60 | 19.7 | 86.75 | (1,666,970.28) |
| Triamcinolone Acetonide (Aristocort A) | 0.1%:15 g,454 g,80 g | Ointment | 489,660.91 | 24,861.60 | 19.7 | 12.22 | 185,964.77 |
| Triamcinolone Acetonide (Aristocort A) | 0.025%:15 g,454 g,80 g | Cream | 489,660.91 | 24,861.60 | 19.7 | 13.33 | 158,368.39 |
| Triamcinolone Acetonide (Triderm) | 0.1%:15 g,30 g,454 g,80 g, 0.5%:15 g | Cream | 489,660.91 | 24,861.60 | 19.7 | 10.22 | 235,687.97 |
| Triamcinolone Acetonide (Kenalog) | 0.025%:15 g | Tube of Ointment | 489,660.91 | 24,861.60 | 19.7 | 7.75 | 297,096.12 |
| Triamcinolone Acetonide (Kenalog) | 0.147 mg/gm:100 g | Bottle of Solution Spray | 489,660.91 | 24,861.60 | 19.7 | 147.32 | (3,172,837.39) |
| Triamcinolone Acetonide (Kenalog) | 0.1%:60mL, 0.025%:60mL | Lotion | 489,660.91 | 24,861.60 | 19.7 | 21.69 | (49,474.58) |
| Gabapentin | - | - | 338,506.64 | 30,735.70 | 11.02 | - | - |
| Sulfamethoxazole/Trimethoprim (Bactrim) | 400-80 mg, 800-160 mg | Tablet | 147,245.02 | 23,256.50 | 6.34 | 6.35 | (232.56) |
| Sulfamethoxazole/Trimethoprim (Sulfatrim) | 200-40 mg/5mL:473mL | Bottle of Suspension | 147,245.02 | 23,256.50 | 6.34 | 28.11 | (506,294.01) |
| Cefuroxime Axetil | 250 mg, 500 mg | Tablet | 681,189.53 | 22,606.10 | 30.14 | 12.20 | 405,553.43 |
| Meclizine Hcl (Travel-Ease) | 25 mg | Tablet | 201,888.98 | 22,085.40 | 9.15 | 5.90 | 71,777.55 |
| Meclizine Hcl (Antivert) | 12.5 mg | Tablet | 201,888.98 | 22,085.40 | 9.15 | 6.50 | 58,526.31 |
| Clindamycin Hcl | 75 mg, 150 mg, 300 mg | Capsule | 238,867.59 | 19,131.80 | 12.49 | 10.60 | 36,159.10 |
| Clindamycin Hcl | 75 mg/5mL:100mL | Solution | 238,867.59 | 19,131.80 | 12.49 | 14.78 | (43,811.82) |
| Clindamycin Hcl | 2%:40 g | Tube of Cream | 238,867.59 | 19,131.80 | 12.49 | 58.36 | (877,575.67) |
| Diazepam | - | - | 71,304.41 | 18,538.90 | 3.85 | - | - |
| Oxycodone Hcl | - | - | 238,487.95 | 17,106.00 | 13.95 | - | - |
| Nystatin (Nystop) | 100,000 unit/g:60 g | Powder | 416,308.04 | 16,329.70 | 25.5 | 16.56 | 145,987.52 |
| Nystatin (Nystex) | 100,000 unit/g:30 g | Ointment | 416,308.04 | 16,329.70 | 25.5 | 9.67 | 258,499.15 |
| Nystatin (Mycostatin) | 100,000 unit/mL:60mL | Bottle of Suspension | 416,308.04 | 16,329.70 | 25.5 | 9.23 | 265,684.22 |
| Nystatin (Mycostatin) | 100,000 unit/g:15 g | Cream | 416,308.04 | 16,329.70 | 25.5 | 7.78 | 289,362.28 |
| Nystatin (Mycostatin) | 500,000 unit | Tablet | 416,308.04 | 16,329.70 | 25.5 | 12.20 | 217,185.01 |
| Levofloxacin | 250 mg, 500 mg, 750 mg | Tablet | 158,952.10 | 14,889.30 | 10.68 | 12.40 | (25,609.60) |
| Levofloxacin | 25 mg/mL:200mL | Bottle of Solution | 158,952.10 | 14,889.30 | 10.68 | 403.91 | (5,854,919.44) |
| Oxycodone Hcl/Acetaminophen | - | - | 120,436.18 | 14,465.00 | 8.33 | - | - |
| Ondansetron (Zofran ODT) | 4 mg | ODT Tablet | 161,994.74 | 14,311.80 | 11.32 | 10.70 | 8,873.32 |
| Ondansetron (Zofran) | 4 mg, 8 mg | Tablet | 161,994.74 | 14,311.80 | 11.32 | 7.40 | 56,102.26 |
| Ondansetron (Zofran) | 4 mg/5mL:50mL | Bottle of Solution | 161,994.74 | 14,311.80 | 11.32 | 14.41 | (44,223.46) |
| Fluconazole | 50 mg, 100 mg, 150 mg, 200 mg | Tablet | 255,304.72 | 14,474.20 | 17.64 | 11.60 | 87,424.17 |
| Doxycycline Monohydrate (Monodox) | 50 mg, 100 mg | Capsule | 247,693.17 | 11,896.40 | 20.83 | 7.85 | 154,415.27 |
| Doxycycline Monohydrate (Adoxa Pak 1/150) | 150 mg | Tablet | 247,693.17 | 11,896.40 | 20.83 | 13.70 | 84,821.33 |
| Doxycycline Monohydrate (Vibramycin Monohydrate) | 25 mg/5mL:60mL | Bottle of Suspension | 247,693.17 | 11,896.40 | 20.83 | 17.31 | 41,875.33 |
| Doxycycline Monohydrate (Adoxa) | 50 mg, 75 mg, 100 mg | Tablet | 247,693.17 | 11,896.40 | 20.83 | 11.10 | 115,751.97 |
| Doxycycline Monohydrate (Adoxa) | 150 mg | Capsule | 247,693.17 | 11,896.40 | 20.83 | 43.40 | (268,501.75) |
| Clotrimazole/Betamethasone Dip | 1%-0.05% | Cream | 281,205.10 | 11,929.60 | 23.58 | 12.27 | 134,923.78 |
| Clotrimazole/Betamethasone Dip | 1%-0.05% | Bottle of Lotion | 281,205.10 | 11,929.60 | 23.58 | 60.38 | (439,009.28) |
| Epinephrine | - | - | 3,053,846.03 | 12,327.80 | 247.73 | - | - |
| Diphth, pertuss(Acell), tet Vac | - | - | 684,358.12 | 10,911.00 | 62.73 | - | - |
| Amitriptyline Hcl | 10 mg, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg | Tablet | 123,441.39 | 15,336.20 | 8.05 | 8.00 | 766.81 |
| Nortriptyline Hcl | 10 mg, 25 mg, 50 mg, 75 mg | Capsule | 158,999.31 | 16,519.10 | 9.63 | 7.18 | 40,471.80 |
| Tobramycin/Dexamethasone | 0.3 − 0.1% | Suspension Dropper | 980,458.62 | 10,021.90 | 97.84 | 27.34 | 706,543.95 |
| Clotrimazole (Mycelex) | 1%:30mL | Bottle of Solution | 442,987.91 | 10,478.40 | 42.28 | 16.16 | 273,695.81 |
| Clotrimazole (Mycelex) | 10 mg | Lozenge | 442,987.91 | 10,478.40 | 42.28 | 14.90 | 286,898.59 |
| Clotrimazole (Lotrimin AF) | 1%:28.4 g | Cream | 442,987.91 | 10,478.40 | 42.28 | 6.50 | 374,917.15 |
| Clotrimazole (Gyne-Lotrimin) | 1%:45 g | Vaginal Cream | 442,987.91 | 10,478.40 | 42.28 | 8.40 | 355,008.19 |
| Tramadol Hcl | - | - | 47,465.15 | 9,975.50 | 4.76 | - | - |
| Chlorhexidine Gluconate | 0.12%:473mL | Bottle of Solution | 61,006.63 | 10,010.10 | 6.1 | 7.11 | (10,110.20) |
| Esomeprazole Magnesium | 20 mg | Delayed Release Tablet | 665,796.35 | 16,232.20 | 41.02 | 12.80 | 458,072.68 |
| Azelastine/Fluticasone | 137-50mcg/Act:23 g | Nasal Spray | 1,426,466.32 | 10,293.80 | 138.58 | 70.28 | 703,066.54 |
| Pilocarpine Hcl (Salagen) | 5 mg, 7.5 mg | Tablet | 663,132.73 | 12,508.90 | 53.02 | 11.90 | 514,365.97 |
| Pilocarpine Hcl (Isoto Carpine) | 4%:15mL, 2%:15mL, 1%:15mL | Bottle of Solution | 663,132.73 | 12,508.90 | 53.02 | 31.65 | 267,315.19 |
| Dexamethasone Sodium Phosphate | - | - | 409,779.69 | 8,374.40 | 48.94 | - | - |
| Prednisolone Acetate | - | - | 459,479.42 | 8,714.30 | 52.73 | - | - |
| Alprazolam | - | - | 52,225.20 | 7,709.90 | 6.78 | - | - |
| Hydrochlorothiazide | 12.5 mg, 25 mg, 50 mg | Tablet | 33,529.08 | 15,378.40 | 2.19 | 6.10 | (60,129.54) |
| Hydrochlorothiazide | 12.5 mg | Capsule | 33,529.08 | 15,378.40 | 2.19 | 6.20 | (61,667.38) |
| Dexamethasone (Dexpak) | 1.5 mg:21 Tablets | 6-day Dose Pack | 151,627.11 | 8,253.90 | 18.38 | 144.76 | (1,043,127.88) |
| Dexamethasone (Dexpak) | 1.5 mg:51 Tablets | 13-day Dose Pack | 151,627.11 | 8,253.90 | 18.38 | 339.21 | (2,648,098.74) |
| Dexamethasone (Dexpak) | 1.5 mg:35 Tablets | 10-day Dose Pack | 151,627.11 | 8,253.90 | 18.38 | 237.97 | (1,812,473.90) |
| Dexamethasone (Decadron) | 0.5 mg, 0.75 mg, 1 mg, 1.5 mg, 2 mg, 4 mg, 6 mg | Tablet | 151,627.11 | 8,253.90 | 18.38 | 13.49 | 40,361.57 |
| Dexamethasone (Decadron) | 0.5 mg/5mL:237mL | Bottle of Elixir | 151,627.11 | 8,253.90 | 18.38 | 16.77 | 13,288.78 |
| Dexamethasone (Decadron) | 0.5 mg/5mL:500mL | Bottle of Solution | 151,627.11 | 8,253.90 | 18.38 | 20.64 | (18,653.81) |
| Dexamethasone (Decadron) | 0.1%:5mL | Solution Dropper | 151,627.11 | 8,253.90 | 18.38 | 43.60 | (208,163.36) |
| Acetaminophen With Codeine | - | - | 40,507.19 | 6,505.00 | 6.23 | - | - |
| Clonazepam | - | - | 57,538.52 | 7,901.30 | 7.29 | - | - |
| Dupilumab | - | - | 22,264,185.90 | 6,408.00 | 3474.44 | - | - |
| Promethazine Hcl | 12.5 mg, 25 mg, 50 mg | Tablet | 33,658.25 | 6,492.20 | 5.19 | 6.35 | (7,530.95) |
| Promethazine Hcl | 12.5 mg:12 Suppositories | Pack of Suppositories | 33,658.25 | 6,492.20 | 5.19 | 26.73 | (139,841.99) |
| Promethazine Hcl | 6.25 mg/5mL:473mL | Bottle of Syrup | 33,658.25 | 6,492.20 | 5.19 | 20.92 | (102,122.31) |
| Valacyclovir Hcl | - | - | 373,840.61 | 7,823.30 | 47.79 | - | - |
| Albuterol Sulfate (AccuNeb) | 0.63 mg/3mL: Box of 25 Vials | Nebulization Solution | 266,843.60 | 6,806.70 | 39.21 | 25.57 | 92,843.39 |
| Albuterol Sulfate (AccuNeb) | 1.25 mg/3mL:75mL | Pack of Inhalation Suspension Vials | 266,843.60 | 6,806.70 | 39.21 | 17.54 | 147,501.19 |
| Albuterol Sulfate (Proventil) | 2.5 mg/0.5mL: Box of 30 Vials | Nebulization Solution | 266,843.60 | 6,806.70 | 39.21 | 20.10 | 130,076.04 |
| Albuterol Sulfate (Proventil) | 2 mg/5mL:473mL | Bottle of Syrup | 266,843.60 | 6,806.70 | 39.21 | 17.80 | 145,731.45 |
| Albuterol Sulfate (Proventil) | 90mcg:6.7 g | Inhaler | 266,843.60 | 6,806.70 | 39.21 | 17.30 | 149,134.80 |
| Albuterol Sulfate (Proventil) | 0.083%:90mL | Pack of Nebulization Solution Vials | 266,843.60 | 6,806.70 | 39.21 | 12.76 | 180,037.22 |
| Albuterol Sulfate (Proventil) | 2 mg, 4 mg | Tablet | 266,843.60 | 6,806.70 | 39.21 | 10.10 | 198,143.04 |
| Lorazepam | - | - | 23,369.88 | 6,092.10 | 3.84 | - | - |
| Ondansetron Hcl | - | - | 45,175.02 | 5,281.80 | 8.56 | - | - |
| Ibuprofen | 200 mg, 400 mg, 600 mg, 800 mg | Tablet | 38,191.71 | 5,351.30 | 7.14 | 6.05 | 5,832.92 |
| Ibuprofen | 100 mg/5mL:118mL | Bottle of Suspension | 38,191.71 | 5,351.30 | 7.14 | 7.89 | (4,013.48) |
| Meloxicam (Vivlodex) | 7.5 mg, 15 mg | Tablet | 25,364.24 | 5,992.70 | 4.24 | 5.75 | (9,048.98) |
| Meloxicam (Mobic) | 5 mg, 10 mg | Capsule | 25,364.24 | 5,992.70 | 4.24 | 273.95 | (1,616,291.12) |
| Clarithromycin | 250 mg, 500 mg | Tablet | 159,620.34 | 4,905.50 | 32.54 | 14.60 | 88,004.67 |
| Sodium Chloride Irrig Solution | - | - | 111,916.75 | 5,070.90 | 22.08 | - | - |
| Lansoprazole | 15 mg, 30 mg | Delayed Release Capsule | 213,869.34 | 8,186.50 | 26.13 | 9.05 | 139,825.42 |
| Olopatadine Hcl (Patanase) | 0.6%:30.5 g | Solution Spray | 460,689.54 | 6,193.80 | 74.38 | 19.60 | 339,296.36 |
| Olopatadine Hcl (Pataday) | 0.1%;5mL | Ophthalmic Solution | 460,689.54 | 6,193.80 | 74.38 | 10.43 | 396,093.51 |
| Betamethasone Valerate (Luxiq) | 0.12%:50 g | Can of Foam | 100,706.69 | 4,006.80 | 25.14 | 27.30 | (8,654.69) |
| Betamethasone Valerate (Betatrex) | 0.1%:15 g | Tube of Ointment | 100,706.69 | 4,006.80 | 25.14 | 13.61 | 46,198.40 |
| Betamethasone Valerate (Beta-Val) | 0.1%:15 g | Tube of Cream | 100,706.69 | 4,006.80 | 25.14 | 8.02 | 68,596.42 |
| Betamethasone Valerate (Beta-Val) | 0.1%:45 g | Cream | 100,706.69 | 4,006.80 | 25.14 | 16.24 | 35,660.52 |
| Betamethasone Valerate (Beta-Val) | 0.1%:60mL | Bottle of Lotion | 100,706.69 | 4,006.80 | 25.14 | 27.40 | (9,055.37) |
| Acetic Acid | 2%:15mL | Bottle of Solution | 88,135.92 | 4,059.70 | 21.71 | 17.61 | 16,644.77 |
| Acyclovir | 200 mg | Capsule | 108,662.82 | 5,551.90 | 19.58 | 6.80 | 70,953.28 |
| Acyclovir | 5%:15 g,30 g | Ointment | 108,662.82 | 5,551.90 | 19.58 | 8.22 | 63,069.58 |
| Acyclovir | 200 mg/5mL:473mL | Suspension 473mL | 108,662.82 | 5,551.90 | 19.58 | 78.82 | (328,894.56) |
| Acyclovir | 400 mg, 800 mg | Tablet | 108,662.82 | 5,551.90 | 19.58 | 8.00 | 64,291.00 |
| Acyclovir | 5%:5 g | Tube of Cream | 108,662.82 | 5,551.90 | 19.58 | 70.81 | (284,423.84) |
The 10 medications associated with the highest losses were Ofloxacin – Floxin ($31,686,025.40), Amoxicillin/Potassium Clavulanate ($23,592,678.68), Doxycycline Hyclate – TargaDOX ($6,285,412.32), Cephalexin – Keflex ($3,568,405.51), Triamcinolone Acetonide – Trianex ($1,666,970.28), Meloxicam – Mobic ($1,616,291.12), Doxycycline Hyclate – Doryx ($1,476,537.48), Cephalexin – Keftab ($1,273,523.47), Sulfamethoxazole/Trimethoprim – Sulfatrim ($506,294.01), Azithromycin ($425,019.44). If MCCPDC was used by Medicare Part D as the source of prescription medications, estimated monthly government overspending on these listed medications would total $72,097,157.71.
When sorting prescriptions by highest monthly expenditure, 34 (45.3%) were not available on the MCCPDC website (Table 2). 27 (36%) new medications were included and compared to Table 1. The 10 medications associated with the highest savings on MCCPDP were Azelastine HCL – Optivar ($10,580,178.71), Azelastine HCL – Astelin ($9,925,397.15), Fluticasone Propionate – Flonase ($5,692,152.58), Mometasone Furoate – Nasonex ($1,213,744.20), Dexlansoprazole ($777,480.61), Tobramycin/Dexamethasone ($706,543.95), Azelastine/Fluticasone ($703,066.54), Budesonide – Pulmicort Respules ($655,191.43), Cefdinir ($561,403.80), Pilocarpine HCL – Salagen ($514,365.97). If the ten listed medications were purchased from MCCPDC, estimated annual costs would be 46.8% of total expenditure by Medicare Part D, totaling $31,329,524.94 in potential monthly savings.
Table 2.
Savings profile for the top 75 otolaryngology medications by total 2022 medicare part D spending
| Medication | Dose (Strength: Volume) | Form | Total 2022 Medicare Part D Spending | Total 2022 30-Day Prescriptions in Medicare Part D | Imputed Monthly Costs for Medicare Part D ($) | Monthly Standard MCCPDC ($) | Potential Savings ($) |
|---|---|---|---|---|---|---|---|
| Dupilumab | - | - | 22,264,185.90 | 6,408.00 | 3474.44 | - | - |
| Fluticasone Propionate (Flonase) | 50mcg:16mL | Nasal Spray | 17,543,104.21 | 1,136,158.20 | 15.45 | 10.44 | 5,692,152.58 |
| Fluticasone Propionate (Cutivate) | 0.005%:15 g | Tube of Ointment | 17,543,104.21 | 1,136,158.20 | 15.45 | 10.87 | 5,203,604.56 |
| Fluticasone Propionate (Cutivate) | 0.05%:60mL | Bottle of Lotion | 17,543,104.21 | 1,136,158.20 | 15.45 | 128.65 | (128,613,108.24) |
| Fluticasone Propionate (Cutivate) | 0.05%:60 g | Cream | 17,543,104.21 | 1,136,158.20 | 15.45 | 20.18 | (5,374,028.29) |
| Fluticasone Propionate (Cutivate) | 0.005%:60gm | Ointment | 17,543,104.21 | 1,136,158.20 | 15.45 | 29.71 | (16,201,615.93) |
| Ipratropium Bromide | 0.02%:30 × 2.5mL | Vial of Solution | 16,796,060.76 | 520,094.30 | 32.3 | 14.58 | 9,216,071.00 |
| Ipratropium Bromide | 0.06%:15mL | Nasal Spray | 16,796,060.76 | 520,094.30 | 32.3 | 20.53 | 6,121,509.91 |
| Ipratropium Bromide | 0.03%:30mL | Nasal Spray | 16,796,060.76 | 520,094.30 | 32.3 | 20.53 | 6,121,509.91 |
| Varicella-Zoster Ge/As01b/Pf | - | - | 16,061,601.00 | 83,030.00 | 193.45 | - | - |
| Azelastine Hcl (Astelin) | 0.1%:30mL | Nasal Spray | 15,635,459.03 | 545,651.30 | 28.66 | 10.47 | 9,925,397.15 |
| Azelastine Hcl (Optivar) | 0.05%:6mL | Solution | 15,635,459.03 | 545,651.30 | 28.66 | 9.27 | 10,580,178.71 |
| Ciprofloxacin Hcl/Dexameth | - | - | 8,082,874.32 | 49,249.10 | 164.13 | - | - |
| Ofloxacin (Floxin) | 300 mg, 400 mg | Tablet | 4,777,483.44 | 95,881.70 | 49.83 | 380.30 | (31,686,025.40) |
| Ofloxacin (Ocuflox) | 0.3%:5mL | Ophthalmic Solution − 5mL | 4,777,483.44 | 95,881.70 | 49.83 | 14.11 | 3,424,894.32 |
| Ofloxacin (Ocuflox) | 0.3%:10mL | Ophthalmic Solution − 10mL | 4,777,483.44 | 95,881.70 | 49.83 | 15.30 | 3,310,795.10 |
| Mometasone Furoate (Nasonex) | 50mcg:17 g | Suspension | 3,467,521.34 | 72,203.70 | 48.03 | 31.22 | 1,213,744.20 |
| Mometasone Furoate (Elocon) | 0.10%:45 g | Cream | 3,467,521.34 | 72,203.70 | 48.03 | 14.15 | 2,446,261.36 |
| Mometasone Furoate (Elocon) | 0.10%:45 g | Ointment | 3,467,521.34 | 72,203.70 | 48.03 | 18.70 | 2,117,734.52 |
| Omeprazole | 20 mg | Delayed Release Capsule | 3,455,167.27 | 482,381.70 | 7.17 | 6.35 | 395,552.99 |
| Famotidine | 10 mg, 20 mg, 40 mg | Tablet | 3,264,958.02 | 444,454.80 | 7.35 | 6.20 | 511,123.02 |
| Famotidine | 40 mg / 5mL:50mL | Suspension 50mL | 3,264,958.02 | 444,454.80 | 7.35 | 25.70 | (8,155,745.58) |
| Montelukast Sodium | 10 mg | Tablet | 3,222,638.37 | 432,946.80 | 7.45 | 6.20 | 541,183.50 |
| Montelukast Sodium | 4 mg | Packet | 3,222,638.37 | 432,946.80 | 7.45 | 34.10 | (11,538,032.22) |
| Montelukast Sodium | 4 mg, 5 mg | Packet | 3,222,638.37 | 432,946.80 | 7.45 | 6.80 | 281,415.42 |
| Fluocinolone Acetonide Oil | - | - | 3,135,136.19 | 53,615.80 | 58.48 | - | - |
| Epinephrine | - | - | 3,053,846.03 | 12,327.80 | 247.73 | - | - |
| Neomycin/Polymyxin B/Hydrocort | 3.5 mg/mL 10,000 unit/mL 1%:10mL | Suspension | 2,425,096.92 | 38,527.60 | 62.95 | 41.40 | 830,269.78 |
| Neomycin/Polymyxin B/Hydrocort | 3.5-10000-1:7.5mL | Solution Dropper | 2,425,096.92 | 38,527.60 | 62.95 | 154.25 | (3,517,569.88) |
| Neomycin/Polymyxin B/Hydrocort | 1%:10mL | Solution | 2,425,096.92 | 38,527.60 | 62.95 | 56.11 | 263,528.78 |
| Amoxicillin/Potassium Clav | 1000-62.5 mg | Extended Release Tablet | 1,906,399.91 | 123,787.60 | 15.41 | 206.00 | (23,592,678.68) |
| Dexlansoprazole | 30 mg, 60 mg | Capsule Delayed Release | 1,618,125.15 | 5,265.70 | 307.3 | 159.65 | 777,480.61 |
| Pantoprazole Sodium | - | - | 1,617,809.41 | 208,988.60 | 7.75 | - | - |
| Levothyroxine Sodium | 25mcg, 75mcg, 100mcg, 137mcg, 150mcg | Tablet | 1,549,498.17 | 144,863.50 | 10.7 | 10.18 | 75,329.02 |
| Sodium, calcium, mag, pot Oxybate | - | - | 1,532,278.16 | 100.00 | 15322.79 | - | - |
| Azelastine/Fluticasone | 137-50mcg/Act:23 g | Nasal Spray | 1,426,466.32 | 10,293.80 | 138.58 | 70.28 | 703,066.54 |
| Sodium Oxybate | - | - | 1,403,344.46 | 73.00 | 19223.9 | - | - |
| Mupirocin | 2%:22 g | Ointment | 1,387,342.74 | 130,041.40 | 10.67 | 7.25 | 444,741.59 |
| Mupirocin | 2%:15 g,30 g | Cream | 1,387,342.74 | 130,041.40 | 10.67 | 19.54 | (1,153,467.22) |
| Levocetirizine Dihydrochloride | 5 mg | Tablet | 1,208,263.83 | 127,773.90 | 9.46 | 6.50 | 378,210.74 |
| Levocetirizine Dihydrochloride | 2.5 mg/5mL:148mL | Solution | 1,208,263.83 | 127,773.90 | 9.46 | 23.74 | (1,824,611.29) |
| Mepolizumab | - | - | 1,182,545.35 | 310.40 | 3809.75 | - | - |
| Omalizumab | - | - | 1,126,986.27 | 392.80 | 2869.11 | - | - |
| Cefdinir | 300 mg | Capsule | 1,091,097.58 | 42,402.10 | 25.74 | 12.50 | 561,403.80 |
| Tobramycin/Dexamethasone | 0.3 − 0.1% | Suspension Dropper | 980,458.62 | 10,021.90 | 97.84 | 27.34 | 706,543.95 |
| Methylprednisolone | 4 mg:21 pack | Blister Pack of 21 Tablets | 918,420.00 | 98,303.80 | 9.35 | 7.74 | 158,269.12 |
| Methylprednisolone | 4 mg, 8 mg, 16 mg, 32 mg | Tablet | 918,420.00 | 98,303.80 | 9.35 | 42.28 | (3,237,144.13) |
| Doxycycline Hyclate (Doryx) | 50 mg, 75 mg, 100 mg, 150 mg, 200 mg | Tablet Delayed Release | 886,088.40 | 43,098.00 | 20.56 | 54.82 | (1,476,537.48) |
| Doxycycline Hyclate (TargaDOX) | 50 mg | Tablet | 886,088.40 | 43,098.00 | 20.56 | 166.40 | (6,285,412.32) |
| Doxycycline Hyclate (Acticlate) | 75 mg, 150 mg | Tablet | 886,088.40 | 43,098.00 | 20.56 | 17.60 | 127,570.08 |
| Doxycycline Hyclate (Lymepak) | 100 mg | Tablet | 886,088.40 | 43,098.00 | 20.56 | 10.40 | 437,875.68 |
| Doxycycline Hyclate (Vibramycin) | 20 mg | Tablet | 886,088.40 | 43,098.00 | 20.56 | 8.90 | 502,522.68 |
| Doxycycline Hyclate (Vibramycin) | 50 mg, 100 mg | Capsule | 886,088.40 | 43,098.00 | 20.56 | 9.50 | 476,663.88 |
| Budesonide/Formoterol Fumarate | 80-4.5mcg/Act:10.2 g Inhaler, 160-4.5mcg/Act:10.2 g Inhaler | Aerosol Inhaler | 866,512.60 | 2,360.00 | 367.17 | 194.50 | 407,501.20 |
| Budesonide (Pulmicort) | 1 mg/2mL:30 Ampules | Carton of Ampules | 834,711.05 | 5,457.20 | 152.96 | 168.82 | (86,551.19) |
| Budesonide (Uceris) | 2 mg:2 Cans | Pack of Foam Canisters | 834,711.05 | 5,457.20 | 152.96 | 623.35 | (2,567,012.31) |
| Budesonide (Uceris) | 9 mg | Tablet Extended Release | 834,711.05 | 5,457.20 | 152.96 | 416.00 | (1,435,461.89) |
| Budesonide (Pulmicort Respules) | 0.25 mg/2mL:60mL (30 × 2mL), 0.5 mg/2mL:60mL (30 × 2mL) | Box of 30 Vials | 834,711.05 | 5,457.20 | 152.96 | 32.90 | 655,191.43 |
| Fluticasone/Vilanterol | - | - | 767,675.45 | 1,973.00 | 389.1 | - | - |
| Prednisone | 5 mg:21 Tablets, 10 mg:48 Tablets | Tablet Therapy Pack | 767,596.02 | 154,360.00 | 4.98 | 13.85 | (1,369,173.20) |
| Prednisone | 1 mg, 2.5 mg, 5 mg, 10 mg, 20 mg, 50 mg | Tablet | 767,596.02 | 154,360.00 | 4.98 | 7.60 | (404,423.20) |
| Prednisone | 5 mg/5mL:120mL | Bottle of Solution | 767,596.02 | 154,360.00 | 4.98 | 85.10 | (12,367,323.20) |
| Fluticasone/Umeclidin/Vilanter | - | - | 758,154.26 | 1,189.00 | 637.65 | - | - |
| Diphth, pertuss(Acell), tet Vac | - | - | 684,358.12 | 10,911.00 | 62.73 | - | - |
| Chenodiol | - | - | 682,914.96 | 12.00 | 56909.58 | - | - |
| Cefuroxime Axetil | 250 mg, 500 mg | Tablet | 681,189.53 | 22,606.10 | 30.14 | 12.20 | 405,553.43 |
| Esomeprazole Magnesium | 20 mg | Delayed Release Tablet | 665,796.35 | 16,232.20 | 41.02 | 12.80 | 458,072.68 |
| Pilocarpine Hcl (Salagen) | 5 mg, 7.5 mg | Tablet | 663,132.73 | 12,508.90 | 53.02 | 11.90 | 514,365.97 |
| Pilocarpine Hcl (Isoto Carpine) | 4%:15mL, 2%:15mL, 1%:15mL | Bottle of Solution | 663,132.73 | 12,508.90 | 53.02 | 31.65 | 267,315.19 |
| Adalimumab | - | - | 647,633.98 | 93.00 | 6963.81 | - | - |
| Lanadelumab-Flyo | - | - | 636,114.44 | 13.00 | 48931.88 | - | - |
| Hydrocodone/Acetaminophen | - | - | 609,375.58 | 73,699.00 | 8.27 | - | - |
| Fluticasone Propion/Salmeterol | - | - | 566,504.03 | 1,804.00 | 314.03 | - | - |
| Immun Glob G(Igg)/Pro/Iga 0–50 | - | - | 507,687.42 | 48.00 | 10576.83 | - | - |
| Triamcinolone Acetonide (Oralone) | 0.1%:5 g | Paste | 489,660.91 | 24,861.60 | 19.7 | 20.78 | (26,850.53) |
| Triamcinolone Acetonide (Trianex) | 0.05%:430 g | Jar of Ointment | 489,660.91 | 24,861.60 | 19.7 | 86.75 | (1,666,970.28) |
| Triamcinolone Acetonide (Aristocort A) | 0.1%:15 g,454 g,80 g | Ointment | 489,660.91 | 24,861.60 | 19.7 | 12.22 | 185,964.77 |
| Triamcinolone Acetonide (Aristocort A) | 0.025%:15 g,454 g,80 g | Cream | 489,660.91 | 24,861.60 | 19.7 | 13.33 | 158,368.39 |
| Triamcinolone Acetonide (Triderm) | 0.1%:15 g,30 g,454 g,80 g, 0.5%:15 g | Cream | 489,660.91 | 24,861.60 | 19.7 | 10.22 | 235,687.97 |
| Triamcinolone Acetonide (Kenalog) | 0.025%:15 g | Tube of Ointment | 489,660.91 | 24,861.60 | 19.7 | 7.75 | 297,096.12 |
| Triamcinolone Acetonide (Kenalog) | 0.147 mg/gm:100 g | Bottle of Solution Spray | 489,660.91 | 24,861.60 | 19.7 | 147.32 | (3,172,837.39) |
| Triamcinolone Acetonide (Kenalog) | 0.1%:60mL, 0.025%:60mL | Lotion | 489,660.91 | 24,861.60 | 19.7 | 21.69 | (49,474.58) |
| Olopatadine Hcl (Patanase) | 0.6%:30.5 g | Solution Spray | 460,689.54 | 6,193.80 | 74.38 | 19.60 | 339,296.36 |
| Olopatadine Hcl (Pataday) | 0.1%;5mL | Ophthalmic Solution | 460,689.54 | 6,193.80 | 74.38 | 10.43 | 396,093.51 |
| Prednisolone Acetate | - | - | 459,479.42 | 8,714.30 | 52.73 | - | - |
| Clotrimazole (Mycelex) | 1%:30mL | Bottle of Solution | 442,987.91 | 10,478.40 | 42.28 | 16.16 | 273,695.81 |
| Clotrimazole (Mycelex) | 10 mg | Lozenge | 442,987.91 | 10,478.40 | 42.28 | 14.90 | 286,898.59 |
| Clotrimazole (Lotrimin AF) | 1%:28.4 g | Cream | 442,987.91 | 10,478.40 | 42.28 | 6.50 | 374,917.15 |
| Clotrimazole (Gyne-Lotrimin) | 1%:45 g | Vaginal Cream | 442,987.91 | 10,478.40 | 42.28 | 8.40 | 355,008.19 |
| Nystatin (Nystop) | 100,000 unit/g:60 g | Powder | 416,308.04 | 16,329.70 | 25.5 | 16.56 | 145,987.52 |
| Nystatin (Nystex) | 100,000 unit/g:30 g | Ointment | 416,308.04 | 16,329.70 | 25.5 | 9.67 | 258,499.15 |
| Nystatin (Mycostatin) | 100,000 unit/mL:60mL | Bottle of Suspension | 416,308.04 | 16,329.70 | 25.5 | 9.23 | 265,684.22 |
| Nystatin (Mycostatin) | 100,000 unit/g:15 g | Cream | 416,308.04 | 16,329.70 | 25.5 | 7.78 | 289,362.28 |
| Nystatin (Mycostatin) | 500,000 unit | Tablet | 416,308.04 | 16,329.70 | 25.5 | 12.20 | 217,185.01 |
| Dexamethasone Sodium Phosphate | - | - | 409,779.69 | 8,374.40 | 48.94 | - | - |
| Azithromycin | 250 mg, 500 mg, 600 mg | Tablet | 402,942.35 | 49,306.20 | 8.18 | 16.80 | (425,019.44) |
| Apremilast | - | - | 381,589.98 | 84.00 | 4542.74 | - | - |
| Valacyclovir Hcl | - | - | 373,840.61 | 7,823.30 | 47.79 | - | - |
| Ciprofloxacin Hcl | - | - | 363,024.80 | 30,158.50 | 12.04 | - | - |
| Cevimeline Hcl | 30 mg:100 Capsules | Bottle of Capsules | 355,916.92 | 2,725.80 | 130.58 | 53.30 | 210,649.82 |
| Hydrocortisone/Acetic Acid | 1–2%:10mL | Solution Dropper | 346,689.08 | 3,321.50 | 104.38 | 96.75 | 25,343.05 |
| Cephalexin (Keflex) | 250 mg, 500 mg, 750 mg | Capsule | 340,962.72 | 45,353.40 | 7.52 | 86.20 | (3,568,405.51) |
| Cephalexin (Keftab) | 250 mg | Tablet | 340,962.72 | 45,353.40 | 7.52 | 35.60 | (1,273,523.47) |
| Gabapentin | - | - | 338,506.64 | 30,735.70 | 11.02 | - | - |
| Tasimelteon | 20 mg | Capsule | 317,452.86 | 12.00 | 26454.41 | 13610.00 | 154,132.92 |
| Vismodegib | - | - | 315,412.41 | 24.00 | 13142.19 | - | - |
| Triamterene/Hydrochlorothiazid | 37.5-25 mg | Capsule | 300,703.93 | 59,900.70 | 5.03 | 6.80 | (106,024.24) |
| Guselkumab | - | - | 293,086.16 | 40.60 | 7218.88 | - | - |
| Ustekinumab | - | - | 291,717.05 | 36.40 | 8014.21 | - | - |
| Clotrimazole/Betamethasone Dip | 1%-0.05% | Cream | 281,205.10 | 11,929.60 | 23.58 | 12.27 | 134,923.78 |
| Clotrimazole/Betamethasone Dip | 1%-0.05% | Bottle of Lotion | 281,205.10 | 11,929.60 | 23.58 | 60.38 | (439,009.28) |
| Albuterol Sulfate (AccuNeb) | 0.63 mg/3mL: Box of 25 Vials | Nebulization Solution | 266,843.60 | 6,806.70 | 39.21 | 25.57 | 92,843.39 |
| Albuterol Sulfate (AccuNeb) | 1.25 mg/3mL:75mL | Pack of Inhalation Suspension Vials | 266,843.60 | 6,806.70 | 39.21 | 17.54 | 147,501.19 |
| Albuterol Sulfate (Proventil) | 2.5 mg/0.5mL: Box of 30 Vials | Nebulization Solution | 266,843.60 | 6,806.70 | 39.21 | 20.10 | 130,076.04 |
| Albuterol Sulfate (Proventil) | 2 mg/5mL:473mL | Bottle of Syrup | 266,843.60 | 6,806.70 | 39.21 | 17.80 | 145,731.45 |
| Albuterol Sulfate (Proventil) | 90mcg:6.7 g | Inhaler | 266,843.60 | 6,806.70 | 39.21 | 17.30 | 149,134.80 |
| Albuterol Sulfate (Proventil) | 0.083%:90mL | Pack of Nebulization Solution Vials | 266,843.60 | 6,806.70 | 39.21 | 12.76 | 180,037.22 |
| Albuterol Sulfate (Proventil) | 2 mg, 4 mg | Tablet | 266,843.60 | 6,806.70 | 39.21 | 10.10 | 198,143.04 |
| Semaglutide | - | - | 262,510.98 | 291.10 | 901.79 | - | - |
| Cyclosporine (Restasis) | 0.05%:12mL (30 × 0.4mL) | Box of 30 Vials (Emulsion) | 260,764.59 | 786.30 | 331.64 | 69.40 | 206,199.31 |
| Cyclosporine (Restasis) | 0.05%:24mL (60 × 0.4mL) | Box of 60 Vials (Emulsion) | 260,764.59 | 786.30 | 331.64 | 130.35 | 158,274.33 |
| Cyclosporine (Sandimmune) | 25 mg:30 Capsules, 100 mg:30 Capsules | Bottle of Capsules | 260,764.59 | 786.30 | 331.64 | 226.05 | 83,025.42 |
| Buprenorphine Hcl/Naloxone Hcl | - | - | 256,580.20 | 770.80 | 332.88 | - | - |
| Fluconazole | 50 mg, 100 mg, 150 mg, 200 mg | Tablet | 255,304.72 | 14,474.20 | 17.64 | 11.60 | 87,424.17 |
| Beclomethasone Dipropionate | - | - | 252,690.75 | 931.00 | 271.42 | - | - |
| Doxycycline Monohydrate (Monodox) | 50 mg, 100 mg | Capsule | 247,693.17 | 11,896.40 | 20.83 | 7.85 | 154,415.27 |
| Doxycycline Monohydrate (Adoxa Pak 1/150) | 150 mg | Tablet | 247,693.17 | 11,896.40 | 20.83 | 13.70 | 84,821.33 |
| Doxycycline Monohydrate (Vibramycin Monohydrate) | 25 mg/5mL:60mL | Bottle of Suspension | 247,693.17 | 11,896.40 | 20.83 | 17.31 | 41,875.33 |
| Doxycycline Monohydrate (Adoxa) | 50 mg, 75 mg, 100 mg | Tablet | 247,693.17 | 11,896.40 | 20.83 | 11.10 | 115,751.97 |
| Doxycycline Monohydrate (Adoxa) | 150 mg | Capsule | 247,693.17 | 11,896.40 | 20.83 | 43.40 | (268,501.75) |
| Clindamycin Hcl | 75 mg, 150 mg, 300 mg | Capsule | 238,867.59 | 19,131.80 | 12.49 | 10.60 | 36,159.10 |
| Clindamycin Hcl | 75 mg/5mL:100mL | Solution | 238,867.59 | 19,131.80 | 12.49 | 14.78 | (43,811.82) |
| Clindamycin Hcl | 2%:40 g | Tube of Cream | 238,867.59 | 19,131.80 | 12.49 | 58.36 | (877,575.67) |
| Oxycodone Hcl | - | - | 238,487.95 | 17,106.00 | 13.95 | - | - |
| Secukinumab | - | - | 232,680.52 | 32.00 | 7271.27 | - | - |
| Apixaban | - | - | 219,968.32 | 560.30 | 392.6 | - | - |
Using the same parameters, the 10 medications associated with the highest losses were Ofloxacin – Floxin ($31,686,025.40), Amoxicillin/Potassium Clavulanate ($23,592,678.68), Doxycycline Hyclate – TargaDOX ($6,285,412.32), Cephalexin – Keflex ($3,568,405.51), Triamcinolone Acetonide – Trianex ($1,666,970.28), Doxycycline Hyclate – Doryx ($1,476,537.48), Cephalexin – Keftab ($1,273,523.47), Azithromycin ($425,019.44), Triamterene/Hydrochlorothiazide ($106,024.24), Budesonide – Pulmicort ($86,551.19). If MCCPDC was used by Medicare Part D as the direct source of prescription medications, estimated government overspending on these listed medications would total $70,167,148.01 monthly.
Discussion
Exploring alternatives to CMS traditional routes is important for reducing federal spending and beneficiary premiums [5]. This is particularly impactful for the field of otolaryngology, as previous research has already shown high markups for certain otolaryngologic services [6]. The contrasting results of potential savings and losses, heavily dependent on the medication, indicate both significant opportunities for cost savings and notable risks of overspending under blanket MCCPDC procurement. This aligns with previous medication-saving evaluations for direct-to-consumer models that imply the efficiency of MCCPDC to be heterogeneous, suggesting that a one-size-fits-all strategy may not be optimal [7].
Of the top 75 otolaryngologic prescription medications sorted by total spending, a substantial 45.3% were not listed on the MCCPDC platform. This is a trend not only for otolaryngologic medications but across a wide range of generics, as merely 26% of expensive generic drugs were available on the MCCPDC website in May 2023, underscoring the pressing need for more affordable access to expensive medications that may not be readily found in alternative drug distribution models [7]. Moreover, a large number of antibiotics were seen within our top 10 potential loss categories, suggesting that Medicare can achieve discounts for specific medication categories within drug distribution models. This is consistent with discussions on Medicare leveraging various factors, such as rebates and pharmacy-related price concessions, to save on prescription drug spending [8]. As a result, providers should carefully consider options before urging patients to order prescription workflows through DTC sources without consulting their Medicare Part D plan in order to re-emphasize our findings of a mix of savings and losses among otolaryngologic medications through theoretical MCCPDC procurement.
Limitations in the present analysis consist of Medicare Part D data not differentiating forms and doses, deeming it difficult to delineate particular medications on MCCPDC. Pricing calculations in the present cost-analysis are subject to fluctuations due to dynamic time and market conditions along with impending and future legislations pertinent to drug pricing and transparency. Only MCCPDC was selected to examine, but other DTC sources have also shown potential savings for Medicare Part D beneficiaries through hybrid approaches, which warrants additional investigation on alternative DTC sources for otolaryngologic medications and determination of the most cost-effective model [2]. Although warehouse clubs (e.g., Costco) have also shown savings on common generic drugs, these clubs are restricted to customers with active membership accounts and have limited medication scope, which hinder the generalization of results to the broader patient population [9]. Moreover, warehouse clubs deem cost-saving analysis complicated as prices are not readily available online for non-members, and hence we excluded them from our study.
Conclusion
Our study conducted a cost analysis utilizing Mark Cuban Cost Plus Drug Company (MCCPDC) for the top 75 most prescribed and expended on otolaryngologic medications. Our results indicate that sourcing select medications from MCCPDC could yield substantial cost savings but also carries risks of overspending for Medicare Part D. We suggest a tailored approach, rather than a uniform adoption of direct-to-consumer models to maximize savings while maintaining comprehensive access.
Author Contributions
Om B. Tripathi: design, analysis, interpretation, manuscript writing; Aman M. Patel: conception, design, analysis, interpretation, manuscript writing; Hassaam S. Choudhry: conception, design, analysis, interpretation, manuscript writing; David E. Wassef: design, analysis, interpretation, manuscript writing; Paul T. Cowan: design, analysis, interpretation, manuscript writing; Richard Chan Woo Park: design, analysis, interpretation, manuscript writing; Andrey Filimonov: design, analysis, interpretation, manuscript writing, final approval;
Funding
None.
Declarations
Level of Evidence
4.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Jung C, Padman R, Anwar S (2019) The impact of medicare part D prescription drug benefit program on generic drug prescription. Med (Baltim) 98(32):e16646. 10.1097/MD.0000000000016646 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Collet DA, Urban MB, Amin A (2024) Potential medicare part D savings on ophthalmic generic drugs. JAMA Ophthalmol 142(7):678–680. 10.1001/jamaophthalmol.2024.1717 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Cortese BD, Chang SS, Talwar R (2023) Urological drug price stewardship: potential cost savings based on the mark Cuban cost plus drug company model. J Urol Published Online Febr. 10.1097/JU.0000000000003083 [DOI] [PubMed] [Google Scholar]
- 4.Cortese BD, Dusetzina SB, Luckenbaugh AN et al (2023) Projected savings for generic oncology drugs purchased via mark Cuban cost plus drug company versus in medicare. J Clin Oncol 41(29):4664–4668. 10.1200/JCO.23.00079 [DOI] [PubMed] [Google Scholar]
- 5.Rha J, Rathi VK, Naunheim MR, Miller LE, Gadkaree SK, Gray ST (2021) Markup on services provided to medicare beneficiaries by otolaryngologists in 2017: implications for surprise billing. Otolaryngol Neck Surg 165(5):662–666. 10.1177/0194599821994826 [DOI] [PubMed] [Google Scholar]
- 6.Berkowitz ST, Groth S, Sternberg P, Patel S (2024) Drug savings for medicare part D beneficiaries using a Direct-to-Consumer model. Ophthalmology 131(4):509–510. 10.1016/j.ophtha.2023.12.004 [DOI] [PubMed] [Google Scholar]
- 7.Lalani HS, Tessema FA, Kesselheim AS, Rome BN (2024) Availability and cost of expensive and common generic prescription drugs: A Cross-sectional analysis of Direct-to-Consumer pharmacies. J Gen Intern Med 39(12):2187–2195. 10.1007/s11606-024-08623-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Feldman WB, Rome BN, Raimond VC, Gagne JJ, Kesselheim AS (2021) Estimating rebates and other discounts received by medicare part D. JAMA Health Forum 2(6):e210626. 10.1001/jamahealthforum.2021.0626 [DOI] [PubMed] [Google Scholar]
- 9.Trish E, Gascue L, Ribero R, Van Nuys K, Joyce G (2021) Comparison of spending on common generic drugs by medicare vs Costco members. JAMA Intern Med 181(10):1414–1416. 10.1001/jamainternmed.2021.3366 [DOI] [PMC free article] [PubMed] [Google Scholar]
